Chronic pain lingers for months or years, often because of ongoing inflammation, nerve changes, or tissue that never fully healed
A 2022 randomized trial of exenatide did not meet its primary endpoint for reducing heavy drinking days in the overall population, though exploratory analyses suggested potential benefits in participants with obesity
The gastric emptying effect is largest in the first 4 to 8 weeks of GLP-1 therapy as plasma concentrations rise to steady state
Health Over Aesthetics Prioritizing health, not just appearance, really changes the game when it comes to aging and weight loss
Biological actions of GLP-1, source: reference [1] Evolution of GLP1 GLP-1RAs Currently, there are nine GLP-1RAs approved for marketing worldwide (Table 1), mainly for the treatment of diabetes and obesity, of which tirzepatide is a novel dual GLP-1RA/GIPR agonist
Split-dose charts for higher doses At certain concentrations, the 8mg and 12mg doses require more liquid than a standard 1mL insulin syringe can hold